Boothbay Fund Management, LLC Biovie Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.75 - $5.17 $24,169 - $45,439	8,789 Added 9.58%	100,518 $342,000
Q2 2023 Aug 14, 2023	BUY	$4.09 - $8.29 $70,650 - $143,201	17,274 Added 23.2%	91,729 $395,000
Q1 2023 May 15, 2023	BUY	$4.89 - $10.53 $308,431 - $664,169	63,074 Added 554.2%	74,455 $601,000
Q4 2022 Feb 14, 2023	BUY	$3.86 - $42.0 $43,930 - $478,002	11,381 New	11,381 $88,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.